Shield Therapeutics plc (STX.L)

GBp 2.75

(0.0%)

EBITDA Summary of Shield Therapeutics plc

Shield Therapeutics plc's latest annual EBITDA in 2023 was -30.28 Million GBP , down -23.29% from previous year.
Shield Therapeutics plc's latest quarterly EBITDA in 2024 Q2 was -10.68 Million GBP , down 0.0% from previous quarter.
Shield Therapeutics plc reported an annual EBITDA of -37.39 Million GBP in 2022, down -30.39% from previous year.
Shield Therapeutics plc reported an annual EBITDA of -17.35 Million GBP in 2021, down -2218.44% from previous year.
Shield Therapeutics plc reported a quarterly EBITDA of -15.42 Million GBP for 2023 Q4, down 0.0% from previous quarter.
Shield Therapeutics plc reported a quarterly EBITDA of -12.41 Million GBP for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Shield Therapeutics plc (2023 - 2014)

Historical Annual EBITDA of Shield Therapeutics plc (2023 - 2014)

Year	EBITDA	EBITDA Growth
2023	-30.28 Million GBP	-23.29%
2022	-37.39 Million GBP	-30.39%
2021	-17.35 Million GBP	-2218.44%
2020	820 Thousand GBP	112.8%
2019	-6.39 Million GBP	-131.4%
2018	-2.76 Million GBP	85.09%
2017	-18.54 Million GBP	-64.73%
2016	-13.65 Million GBP	50.14%
2015	-22.56 Million GBP	-92.28%
2014	-11.73 Million GBP	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-10.68 Million GBP	0.0%
2023 Q4	-15.42 Million GBP	0.0%
2023 Q2	-12.41 Million GBP	0.0%
2023 FY	- GBP	-23.29%
2022 Q2	-10.64 Million GBP	0.0%
2022 FY	- GBP	-30.39%
2022 Q4	-13.4 Million GBP	0.0%
2021 Q2	-6.35 Million GBP	0.0%
2021 Q4	-12.51 Million GBP	0.0%
2021 FY	- GBP	-2218.44%
2020 Q4	-3.12 Million GBP	0.0%
2020 Q2	3.67 Million GBP	0.0%
2020 FY	- GBP	112.8%
2019 FY	- GBP	-131.4%
2019 Q2	-998 Thousand GBP	0.0%
2018 Q4	4.1 Million GBP	0.0%
2018 FY	- GBP	85.09%
2018 Q2	- GBP	0.0%
2017 FY	- GBP	-64.73%
2017 Q2	- GBP	0.0%
2017 Q4	- GBP	0.0%
2016 Q4	- GBP	0.0%
2016 FY	- GBP	50.14%
2016 Q2	- GBP	0.0%
2015 FY	- GBP	-92.28%
2014 FY	- GBP	0.0%

Peer EBITDA Comparison of Shield Therapeutics plc

Name	EBITDA	EBITDA Difference